Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Frontiers in Oncology
|
October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
Nicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Biomedicines
|
July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
Yue Liao, Susann Badmann, Till Kaltofen, et al.
Journal of Reproductive Immunology
|
March 16, 2024
Placental expression of inflammatory Galectin-12 is associated with gestational diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2025
Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT<sup>®</sup> Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH
Alexander Tamalunas, Felix Schierholz, Henrik Poth, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
Juliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Biomedicines
|
February 25, 2022
<i>FAM111A</i> Is a Novel Molecular Marker for Oocyte Aging
Huixia Yang, Thomas Kolben, Mirjana Kessler, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 9, 2024
Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions
Alexander Tamalunas, Amin Wendt, Florian Springer, et al.
BMC Cancer
|
April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
Anna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Frontiers in Oncology
|
October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
Nicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Biomedicines
|
July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
Yue Liao, Susann Badmann, Till Kaltofen, et al.
Journal of Reproductive Immunology
|
March 16, 2024
Placental expression of inflammatory Galectin-12 is associated with gestational diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2025
Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT<sup>®</sup> Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH
Alexander Tamalunas, Felix Schierholz, Henrik Poth, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
Juliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Biomedicines
|
February 25, 2022
<i>FAM111A</i> Is a Novel Molecular Marker for Oocyte Aging
Huixia Yang, Thomas Kolben, Mirjana Kessler, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 13, 2022
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 9, 2024
Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions
Alexander Tamalunas, Amin Wendt, Florian Springer, et al.
BMC Cancer
|
April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
Anna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
Page
of 11